NIH grants plummeted $2.3 billion in Trump’s first months, as federal-academia partnership crumbles
The NIH has scaled back its awards of new grants by at least $2.3 billion since the beginning of the year, a STAT analysis shows.
Related Articles
20 attorneys general ask federal judge to reverse deep cuts to HHS
Attorneys general in 19 states and Washington, D.C., are challenging HHS cuts, saying the massive restructuring has destroyed lifesaving programs and left states to pick up…
Hospitals and patient groups ramp up opposition to Medicaid cuts as House mulls options
Cuts to the health insurance program are on the table as GOP lawmakers look for ways to pay for President Trump’s tax cuts.
Bristol Myers Squibb CEO: Pharmaceutical innovation requires bold yet predictable U.S. policy
Bristol Myers Squibb CEO warns against “slashing U.S. investment in medicines or importing lackluster policies of less innovative health care systems.”
Trump signs order in bid to boost pharma manufacturing in the U.S.
Federal agencies, including the FDA and the EPA, were ordered to accelerate approval of domestic manufacturing plants.
Europe unveils $565 million package to retain scientists, and attract new ones
The European Commission unveiled a $565 million package to retain and attract scientists, as other countries try to leverage the dismantling of research programs in…
Trump signs order in bid to boost pharma manufacturing in the U.S.
Federal agencies, including the FDA and the EPA, were ordered to accelerate approval of domestic manufacturing plants.
Vertex reports an earnings miss and pause on cystic fibrosis trial
Vertex shares fell in after-hours trading, as investors considered a stock trading near its all-time high with a longer wait for its next leg of…
Charles Lieber, ex-Harvard chemist convicted of lying about ties to China, joins faculty of Chinese university
Charles Lieber, the former chair of Harvard’s chemistry department who was convicted of lying to federal agents about his ties to China, was recently announced as…
Charles Lieber, ex-Harvard chemist convicted of lying about ties to China, joins faculty of Chinese university
Charles Lieber, the former chair of Harvard’s chemistry department who was convicted of lying to federal agents about his ties to China, was recently announced as…
Bristol Myers Squibb CEO: Pharmaceutical innovation requires bold yet predictable U.S. policy
Bristol Myers Squibb CEO warns against “slashing U.S. investment in medicines or importing lackluster policies of less innovative health care systems.”